CT Enterprise (03839) announced its interim results, with a shareholders' attributable profit of 17.046 million US dollars, representing a year-on-year increase of 768.36%.

CT Enterprise (03839) announced its mid-year performance for 2025, with revenue of approximately 323 million US dollars, a year-on-year increase of 199.44%; the company's shareholders' net profit attributable was 17.046 million US dollars, a year-on-year increase of 768.36%; earnings per share were 6.7 US cents. The announcement stated that the increase in profit was mainly due to significant growth in the group's biochemical business.